GE Capital
GE Capital, established in 1932, is a global financial services provider headquartered in Norwalk, Connecticut. As a subsidiary of General Electric, it offers a wide array of financial services and products tailored to businesses of all sizes across various industries. These services include commercial loans and leases, equipment financing, debt financing, structured equity, fleet management, and financial programs. GE Capital operates in over 35 countries, serving sectors such as healthcare, manufacturing, energy, aviation, infrastructure, and more. It combines deep industry expertise with global reach to deliver innovative, reliable, and competitively priced financing solutions.
Micell Technologies
Series B in 2009
Micell Technologies is a biomedical device company that specializes in the development of interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in North Carolina, the company offers a range of innovative products, including the MiStent, a drug-eluting stent that combines the therapeutic benefits of sirolimus with the characteristics of a bare-metal stent. In addition to MiStent, Micell develops drug-coated balloons for delivering sirolimus to arterial walls during procedures such as percutaneous transluminal angioplasty and stent implantation, as well as bioresorbable scaffolds and peripheral drug-eluting stents. The company's advanced technology utilizes supercritical fluid processes to optimize drug release and enhance healing, aiming to improve safety and clinical outcomes for patients with cardiovascular diseases. Micell also provides clinical trials and health economics services to support its product development and market integration.
Micell Technologies
Series A in 2007
Micell Technologies is a biomedical device company that specializes in the development of interventional cardiology systems for vascular drug delivery. Founded in 1995 and based in North Carolina, the company offers a range of innovative products, including the MiStent, a drug-eluting stent that combines the therapeutic benefits of sirolimus with the characteristics of a bare-metal stent. In addition to MiStent, Micell develops drug-coated balloons for delivering sirolimus to arterial walls during procedures such as percutaneous transluminal angioplasty and stent implantation, as well as bioresorbable scaffolds and peripheral drug-eluting stents. The company's advanced technology utilizes supercritical fluid processes to optimize drug release and enhance healing, aiming to improve safety and clinical outcomes for patients with cardiovascular diseases. Micell also provides clinical trials and health economics services to support its product development and market integration.
Buildnet offers management software to homebuilders. Its product, BuildNet, Inc. Exchange, provides internet-based procurement, e-commerce, and information services to homebuilders, suppliers, and manufacturers. Buildnet is based in Durham, North Carolina, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.